← All agents | ← Research tracker
Ritonavir
PubChem entry
Evidence Summary
Evidence Level: Preliminary
Mechanism: Antiviral / Persistence, Enrollment: Actual, Sponsor Type: Other, Unknown / General
Safety: Limited specific safety data in these populations. Review full prescribing information and consult specialist. Many agents used off-label or investigational.
Dosing: See linked studies/trials for reported doses and durations; typical protocols vary widely.
Investigational for listed conditions. 3 associated trial(s) and 0 study reference(s) in current data. Review primary sources and consult specialists before use.
Related Conditions
Long COVID (no page yet)
Clinical Trials
3 trial(s) registered
NCT05965726: RECOVER-VITAL: Platform Protocol, Appendix to Measure the Effects of Paxlovid on Long COVID Symptoms PHASE2 COMPLETED
NCT05576662: Paxlovid for Treatment of Long Covid PHASE2 COMPLETED
NCT05668091: A Decentralized, Randomized Phase 2 Efficacy and Safety Study of Nirmatrelvir/Ritonavir in Adults with Long COVID. PHASE2 COMPLETED
Key Studies / References